HowardEllisEdelsteinMD

PubMed

• 1 citations
  Similar neurocognitive outcomes after 48 weeks in HIV-1-infected participants randomized to continue tenofovir/emtricitabine + atazanavir/ritonavir or simplify to abac...
  Kevin Robertson, Paul Maruff, Lisa L. Ross, David A. Wohl, Catherine B. Small, Howard Edelstein, Mark S. Shaefer> ;Journal of Neurovirology. 2019 Feb 1
• 16 citations
  The ASSURE study: HIV-1 suppression is maintained with bone and renal biomarker improvement 48 weeks after ritonavir discontinuation and randomized switch to abacavir/...
  David A. Wohl, Laveeza Bhatti, Catherine B. Small, Howard Edelstein, Henry H. Zhao, David A. Margolis, Edwin DeJesus, Winkler G. Weinberg, Lisa L. Ross, Shaefer> ;HIV Medicine. 2016 Feb 1
• 4 citations
  Treatment of HIV in outpatients with schizophrenia, schizoaffective disorder and bipolar disease at two county clinics.
  Kaitlyn Murphy, Howard Edelstein, Lance Smith, Kathleen Clanon, Beth Schweitzer, Leslie Reynolds, Precilla Wheeler> ;Community Mental Health Journal. 2011 Mar 8
• 4 citations
  Failure of treatment of tuberculous adenitis due to an unexpected drug interaction with rifabutin and efavirenz.
  Howard E. Edelstein, Yolanda Cuadros> ;AIDS. 2004 Aug 20
• Internal warts and associated anal diseases are common in patients attending a county HIV clinic.
  Howard Edelstein, J. Trees Ritter> ;Journal of Acquired Immune Deficiency Syndromes. 2004 Aug 1
• 10 citations
  Antiretroviral medication errors were universal in hospitalized HIV-seropositive patients at a teaching hospital.
  Howard Edelstein, Michael R. Wilson> ;Journal of Acquired Immune Deficiency Syndromes. 2001 Dec 1
• 39 citations
  Decision-making speed in HIV-1 infection: a preliminary report.
  Eileen M. Martin, Donna J. Sorensen, Howard E. Edelstein, Lynn C. Robertson> ;AIDS. 1992 Jan 1
• Pneumococcal bacteremia as a marker for human immunodeficiency virus infection in patients without AIDS.
  Chirurgi, V. A., Edelstein, H., McCabe, R.> ;South Med J. 1990 Aug
• Join now to see all